Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia

Islet transplantation in diabetes is hampered by the need of life-long immunosuppression. Encapsulation provides partial immunoprotection but could possibly limit oxygen supply, a factor that may enhance hypoxia-induced beta cell death in the early posttransplantation period. Here we tested suscepti...

Full description

Saved in:
Bibliographic Details
Main Authors: I. K. Hals, A. M. Rokstad, B. L. Strand, J. Oberholzer, V. Grill
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2013/374925
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841524532646510592
author I. K. Hals
A. M. Rokstad
B. L. Strand
J. Oberholzer
V. Grill
author_facet I. K. Hals
A. M. Rokstad
B. L. Strand
J. Oberholzer
V. Grill
author_sort I. K. Hals
collection DOAJ
description Islet transplantation in diabetes is hampered by the need of life-long immunosuppression. Encapsulation provides partial immunoprotection but could possibly limit oxygen supply, a factor that may enhance hypoxia-induced beta cell death in the early posttransplantation period. Here we tested susceptibility of alginate microencapsulated human islets to experimental hypoxia (0.1–0.3% O2 for 8 h, followed by reoxygenation) on viability and functional parameters. Hypoxia reduced viability as measured by MTT by 33.8±3.5% in encapsulated and 42.9±5.2% in nonencapsulated islets (P<0.2). Nonencapsulated islets released 37.7% (median) more HMGB1 compared to encapsulated islets after hypoxic culture conditions (P<0.001). Glucose-induced insulin release was marginally affected by hypoxia. Basal oxygen consumption was equally reduced in encapsulated and nonencapsulated islets, by 22.0±6.1% versus 24.8±5.7%. Among 27 tested cytokines/chemokines, hypoxia increased the secretion of IL-6 and IL-8/CXCL8 in both groups of islets, whereas an increase of MCP-1/CCL2 was seen only with nonencapsulated islets. Conclusion. Alginate microencapsulation of human islets does not increase susceptibility to acute hypoxia. This is a positive finding in relation to potential use of encapsulation for islet transplantation.
format Article
id doaj-art-3dd24b03a5a149f9a650af9dd621d9d9
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-3dd24b03a5a149f9a650af9dd621d9d92025-02-03T05:52:59ZengWileyJournal of Diabetes Research2314-67452314-67532013-01-01201310.1155/2013/374925374925Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute HypoxiaI. K. Hals0A. M. Rokstad1B. L. Strand2J. Oberholzer3V. Grill4Department of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Postbox 8905, 7491 Trondheim, NorwayDepartment of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Postbox 8905, 7491 Trondheim, NorwayDepartment of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Postbox 8905, 7491 Trondheim, NorwayDepartment of Surgery, University of Illinois, IL at Chicago, Chicago, IL 60612, USADepartment of Cancer Research and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Postbox 8905, 7491 Trondheim, NorwayIslet transplantation in diabetes is hampered by the need of life-long immunosuppression. Encapsulation provides partial immunoprotection but could possibly limit oxygen supply, a factor that may enhance hypoxia-induced beta cell death in the early posttransplantation period. Here we tested susceptibility of alginate microencapsulated human islets to experimental hypoxia (0.1–0.3% O2 for 8 h, followed by reoxygenation) on viability and functional parameters. Hypoxia reduced viability as measured by MTT by 33.8±3.5% in encapsulated and 42.9±5.2% in nonencapsulated islets (P<0.2). Nonencapsulated islets released 37.7% (median) more HMGB1 compared to encapsulated islets after hypoxic culture conditions (P<0.001). Glucose-induced insulin release was marginally affected by hypoxia. Basal oxygen consumption was equally reduced in encapsulated and nonencapsulated islets, by 22.0±6.1% versus 24.8±5.7%. Among 27 tested cytokines/chemokines, hypoxia increased the secretion of IL-6 and IL-8/CXCL8 in both groups of islets, whereas an increase of MCP-1/CCL2 was seen only with nonencapsulated islets. Conclusion. Alginate microencapsulation of human islets does not increase susceptibility to acute hypoxia. This is a positive finding in relation to potential use of encapsulation for islet transplantation.http://dx.doi.org/10.1155/2013/374925
spellingShingle I. K. Hals
A. M. Rokstad
B. L. Strand
J. Oberholzer
V. Grill
Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
Journal of Diabetes Research
title Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
title_full Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
title_fullStr Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
title_full_unstemmed Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
title_short Alginate Microencapsulation of Human Islets Does Not Increase Susceptibility to Acute Hypoxia
title_sort alginate microencapsulation of human islets does not increase susceptibility to acute hypoxia
url http://dx.doi.org/10.1155/2013/374925
work_keys_str_mv AT ikhals alginatemicroencapsulationofhumanisletsdoesnotincreasesusceptibilitytoacutehypoxia
AT amrokstad alginatemicroencapsulationofhumanisletsdoesnotincreasesusceptibilitytoacutehypoxia
AT blstrand alginatemicroencapsulationofhumanisletsdoesnotincreasesusceptibilitytoacutehypoxia
AT joberholzer alginatemicroencapsulationofhumanisletsdoesnotincreasesusceptibilitytoacutehypoxia
AT vgrill alginatemicroencapsulationofhumanisletsdoesnotincreasesusceptibilitytoacutehypoxia